MENU
Advertisement
Show Filters
Refine by Content Type
Refine by Year
Sort By:
Choose Sites to Search:
Targeted Renal Therapy
A novel device holds promise in preventing and treating renal insufficiency.
By David E. Allie, MD; Barry S. Weinstock, MD; and Paul Teirstein, MD
CE Mark Approved for Vivasure Medical's Fully Bioabsorbable Percutaneous Closure Device for Large-Bore Transcatheter Procedures
January 8, 2016—Vivasure Medical announced European CE Mark approval of its fully bioabsorbable percutaneous vascular closure device for large-bore femoral arteriotomies.
